Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

Cancer

Volumn 86, Issue 2, 1999, Pages 331-339

  Russo, Carolyn ^a,c   Pellarin, Malgorzata ^a   Tingby, Ola ^b   Bollen, Andrew W ^a   Lamborn, Kathleen R ^a   Mohapatra, Gayatry ^a   Collins, V Peter ^b   Feuerstein, Burt G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comparative genomic hybridization; Infratentorial; Medulloblastoma; Primitive neuroectodermal tumor; Supratentorial

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CEREBELLUM TUMOR; CHILD; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME ABERRATION; COMPARATIVE STUDY; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; FEMALE; GENOME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROECTODERM TUMOR; PRIORITY JOURNAL; TUMOR LOCALIZATION;

EID: 0033565715     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19990715)86:2<331::aid-cncr18>3.0.co;2-%23     Document Type: Article

References (37)

1. Cohen ME, Duffner PK. Brain tumors in children: Principles of diagnosis and treatment-second edition. New York: Raven Press.
2. Jenkin D, Goddard K, Armstrong D, Becker, L, Berry M, Chan H, et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 1990;19:265-74.
3. Tait DM, Thorton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society for Paediatric Oncology (SIOP I). Eur J Cancer 1990;26:464-9.
4. Whelan HT, Krouwer HG, Schmidt MH, Reichert KW, Kovnar EH. Current therapy and new perspectives in the treatment of medulloblastoma. Pediatr Neurol 1998;18: 103-15.
5. Calaminus G, Janssen G, Lenard HG, Bock WJ, Reifenberger G, Schmitt G, et al. Combined therapy of medulloblastoma: review of 46 patients treated in a single institution. Neuropediatrics 1998;29:102-7.
6. Park TS, Hoffman JH, Hendrich EB, Humphreys RP, Becker LE. Medulloblastoma, clinical presentation and management. Experience at the Hospital for Sick Children, Toronto, 1950-1980. J Neurosurg 1983;58:543-52.
7. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991;74:433-40.
8. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson S, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine. J Neurosurg 1994;81:690-8.
9. Dirks PB, Harris L, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT. Supratentorial primitive neuroectodermal tumors in children. J Neurooncol 1996;29(1):75-84.
10. Albright AL, Wisoff JH, Zeltzer P, Boyett J, Rorke LB, Stanley P, et al. Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. Pediatr Neurosurg 1995;22:1-7.
11. Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay JL, et al. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Children's Cancer Group randomized trial. J Clin Oncol 1995;13:1687-96.
12. Jakacki RI, Zeltzer PM, Boyett JM, Albright AL, Allen JC, Geyer JR, et al. Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Children's Cancer Group. J Clin Oncol 1995;13: 1377-83.
13. Tomlinson FH, Scheithauer BW, Meyer FB, Smithson WA, Shaw EG, Miller GM, et al. Medulloblastoma: I. Clinical, diagnostic, and therapeutic overview. J Child Neural 1992; 7:142-55.
14. Evans AE, Jenkin RDT, Sposto R, Ortega JA, Wilson CB, Wara W, et al. The treatment of medulloblastoma: the results of a prospective randomized trial of radiation therapy with and without nitrosourea, vincristine and prednisone. J Neurosurg 1990;72:572-82.
15. Kallioniemi OP, Kallioniemi A, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Can Biol 1993;4(1):41-6.
16. Feuerstein BG, Mohapatra G. Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas. J Neuro-Oncol 1995;24:47-55.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 1st ed. Cold Spring Harbor, NY: Cold Spring Laboratory Press, 1989.
18. Mohapatra G, Kim DH, Feuerstein BG. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer 1995;13:86-93.
19. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi OP, Waldman F, et al. Computer image analysis of comparative genomic hybridization. Cytometry 1995;19(1):4-26.
20. Mohapatra G, Moore D, Sudar D, Pinkel D, Gray J, Feuerstein BG. A statistical method for the analysis of comparative genomic hybridization profiles. Sixth International Workshop on Chromosomes in Solid Tumors: Tuscon, AZ, 1995.
21. Heim S, Mitelman F. Cancer cytogenetics, 2nd ed. New York: Wiley-Liss, 1995.
22. Fujii Y, Hongo T, Hayashi Y. Chromosome analysis of brain tumors in childhood. Genes Chromosomes Cancer 1994;11: 205-15.
23. Cogen PH, Daneshvar L, Metzger AK, Duyk G, Edwards MSB, Sheffield VC. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 1992;50: 584-9.
24. Vagner-Capodano AM, Zattara-Cannoni H, Gambarelli D, Gentet JC, Genitori L, Lena G, et al. Detection of i(17q) chromosome by fluorescent in situ hybridization (FISH) with interphase nuclei in medulloblastoma. Cancer Genet Cytogenet 1994;78:1-6.
25. Thomas GA, Raffel C. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system. Cancer Res 1991;51: 639-43.
26. Scheyrlen WG, Schwabe GC, Joos S, Mollenhauer J, Sorenson N, Kuhl J. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 1998;16:2478-85.
27. Stuart AG, Pearson ADJ, Emslie J, Lennard A, Davison EV, Perry RH, et al. Cytogenetic abnormalities in a disseminated medulloblastoma. Med Pediatr Oncol 1993;21:295-8.
28. Phelan CM, Liu L, Ruttledge MH, Muntzning K, Ridderheim P, Collins VP. Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours. Hum Genet 1995;96:684-90.
29. Sawyer IR, Swanson CM, Roloson GJ, Longee DC, Boop FA, Chadduck WM. Molecular cytogenetic analysis of a medulloblastoma with isochromosome 17 and double minutes. Cancer Genet Cytogenet 1991;57:181-6.
30. Batra SK, McLendon RE, Koo JS, Castelino-Prabhu S, Fuchs HE, Krischer JP, et al. Prognostic implications of chromosome 17p deletions in human medulloblastoma. J Neuro-Oncol 1995;24:39-45.
31. Biegel JA. Genetics of pediatric central nervous system tumors. J Pediatr Hematol Oncol 1997;19(6):492-501.
32. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272(5268):1668-71.
33. Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, et al. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 1997;57(12): 2369-72.
34. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997;277(5329):1109-13.
35. Schutz BR, Scheurlen W, Krauss J, du Manoir S, Joos S, Bentz M, et al. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1996;16:196-203.
36. Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, et al. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 1997;57:4042-7.
37. Minn Y, Mohapatra G, Bollen A, Burger P, Jenkins R, Feuerstein B. Genetic subtypes in gliomas with oligodendroglial components. Society for Neuro-oncology, 1997, p94A.